经尿道铥激光前列腺剜除术治疗良性前列腺增生的临床疗效分析  

Clinical Efficacy Analysis of Transurethral Thulium Laser Enucleation of Prostate for Benign Prostatic Hyperplasia

作　　者：封志强 郑玲 林盛强 陈德敏 张旭 FENG Zhi-qiang;ZHENG Ling;LIN Sheng-qiang;CHEN De-min;ZHANG Xu(Urology Department of Nanping First Hospital Affiliated to Fujian Medical University,Fujian Nanping 353000)

机构地区：[1]福建医科大学附属南平第一医院泌尿外科,福建南平353000

出　　处：《中国医疗器械信息》2024年第19期153-155,共3页China Medical Device Information

摘　　要：目的:分析在良性前列腺增生(BPH)治疗中用经尿道铥激光前列腺剜除术(ThuLEP)治疗的应用价值。方法:将2019年1月~2022年12月本院收治的400例BPH患者为本次研究对象,以随机法(数字表法)分组,观察组200例采取ThuLEP,对照组200例采取常规(等离子剜除)治疗,比较两组治疗后手术指标(手术时间、导尿管留置时间、住院时间)、并发症发生率(尿路感染、短暂性尿失禁、膀胱颈萎缩),分析两组治疗前后最大尿流率、视觉模拟评分、国际前列腺症状评分。结果:观察组治疗后手术各项指标均短于对照组,并发症发生率低(P<0.05);最大尿流率、视觉模拟评分与国际前列腺症状评分评分比较,观察组与对照组治疗前差异均不显著(P>0.05),观察组与对照组治疗后可见观察组各项指标改善更明显(P<0.05)。结论:在BPH患者治疗中用ThuLEP治疗可提高临床疗效,降低术后并发症,改善排尿困难症状,较常规手术更能减轻身体损伤,降低术后疼痛程度,促进术后康复。Objective:To analyze the application value of transurethral thulium laser enucleation of prostate(ThuLEP)in the treatment of symptomatic prostatic hyperplasia(BPH).Methods:Taking 400 symptomatic BPH patients admitted to our hospital in recent years(from January 2019 to December 2022)as the subjects of this study,group by random method(numerical table method),observation group of 200 patients were treated with laser enucleation(ThuLEP),the control group of 200 patients were treated with conventional(plasma enucleation),compare the two post-treatment surgical indicators(operation time,catheter retention time,hospital time),complication rate(urinary tract infection,transient urinary incontinence,bladder neck atrophy),the maximum urinary flow rate before and after treatment in the two groups Qmax(the maximum flow rate),VAS(visual analogue score),IPSS(international prostate symptom score).Results:All the surgical indicators were shorter than those of the control group,and the complication rate was low(P<0.05);Comparison of Qmax,VAS and IPSS scores:the difference between the observation group was not significant(P>0.05),and the observation group and the control group improved more significantly(P<0.05).Conclusion:The use of ThuLEP in the treatment of symptomatic BPH patients can improve clinical efficacy,reduce postoperative complications,improve the symptoms of dysuria,reduce physical injury,reduce postoperative pain and promote postoperative rehabilitation compared with conventional surgery.

关 键 词：经尿道铥激光前列腺剜除术 良性前列腺增生 前列腺症状评分 

分 类 号：R699[医药卫生—泌尿科学]